Wrapmanager Inc. raised its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 2.1% during the second quarter, according to its most recent filing with the SEC. The fund owned 10,178 shares of the medical equipment provider’s stock after buying an additional 207 shares during the period. Wrapmanager Inc.’s holdings in Smith & Nephew SNATS were worth $355,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Cambiar Investors LLC boosted its stake in shares of Smith & Nephew SNATS by 2.8% in the second quarter. Cambiar Investors LLC now owns 5,288,915 shares of the medical equipment provider’s stock valued at $184,319,000 after buying an additional 145,159 shares during the period. Nuance Investments LLC boosted its stake in shares of Smith & Nephew SNATS by 6.5% in the first quarter. Nuance Investments LLC now owns 2,147,255 shares of the medical equipment provider’s stock valued at $66,415,000 after buying an additional 131,388 shares during the period. Bank of America Corp DE boosted its stake in shares of Smith & Nephew SNATS by 10.9% in the first quarter. Bank of America Corp DE now owns 1,526,036 shares of the medical equipment provider’s stock valued at $47,200,000 after buying an additional 149,672 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Smith & Nephew SNATS by 4.7% in the first quarter. Renaissance Technologies LLC now owns 734,000 shares of the medical equipment provider’s stock valued at $22,703,000 after buying an additional 32,750 shares during the period. Finally, Dalton Greiner Hartman Maher & Co. boosted its stake in shares of Smith & Nephew SNATS by 2,645.8% in the second quarter. Dalton Greiner Hartman Maher & Co. now owns 497,676 shares of the medical equipment provider’s stock valued at $17,344,000 after buying an additional 479,551 shares during the period. 7.17% of the stock is currently owned by hedge funds and other institutional investors.

Smith & Nephew SNATS, Inc. (NYSE:SNN) opened at 35.31 on Tuesday. The firm has a market capitalization of $15.46 billion, a price-to-earnings ratio of 17.98 and a beta of 0.76. The stock’s 50 day moving average is $34.91 and its 200 day moving average is $33.06. Smith & Nephew SNATS, Inc. has a 1-year low of $26.97 and a 1-year high of $35.85.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.watchlistnews.com/wrapmanager-inc-has-355000-stake-in-smith-nephew-snats-inc-snn/1490608.html.

SNN has been the topic of several analyst reports. BidaskClub cut shares of Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Zacks Investment Research raised shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $40.00 price target on the stock in a research report on Wednesday, June 7th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $38.00.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.